Craig Milner, MD
Vascular Surgery · Temple, TXNPI 1396189726
Payments from drug & device makers
Across 72 payments — averaging $193.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- W. L. Gore & Associates, Inc.$3K
- Cook Medical LLC$322
- Silk Road Medical, Inc.$143
- Triad Life Sciences Inc.$67
- Neuros Medical, Inc.$51
- plus $54 from 2 others
What the payments were for
- Grants$8,17259%
- Travel & lodging$1,2119%
- Food & beverage$4,14430%
- Education$4113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 28 | $10,294 |
| W. L. Gore & Associates, Inc. | 35 | $3,009 |
| Cook Medical LLC | 3 | $322 |
| Silk Road Medical, Inc. | 1 | $143 |
| Triad Life Sciences Inc. | 1 | $67 |
| Neuros Medical, Inc. | 2 | $51 |
| Solventum Corporation | 1 | $28 |
| Shockwave Medical, Inc | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$8,309
- ELLIPSYS VASCULAR ACCESS SYSTEM$698
- EXCLUDER AAA Endoprosthesis$672
- ENDURANT IIS$621
- GORE VIABAHN VBX Balloon Expandable Endo$209
- GORE VIABAHN Endoprosthesis with Heparin$207
- VIABAHN VBX Balloon Expandable Endoprosthesis$190
- ENROUTE .014 Guidewire$143
- ENROUTE Transcarotid Stent$143
- ENROUTE Transcarotid Neuroprotection System$143
- ENHANCE Transcarotid Peripheral Access Kit$143
- Vascular Graft$133
- Dryseal Sheath$131
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$123
- Zenith Spiral-Z$118
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$110
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$107
- TAG Thoracic Endoprosthesis$105
How this compares
$13,940 in reported general payments places this provider in the 65th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 20 | $439 |
| Gabapentin | 14 | $217 |
| Atorvastatin Calcium | 12 | $135 |
| Tramadol Hcl | 17 | $22 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Temple
- William BohannonTemple$82K
- Mazin FotehAustin$2.5M
- Alan LumsdenHouston$2.4M
- Gregory PearlDallas$2.3M
- Gustavo OderichHouston$999K
- Michael SiahDallas$838K
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
- Carlos TimaranDallas$527K
- Samuel LeonardHouston$431K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.